Category Archives: Ophthalmics

Oculos Partner Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials

RUSH, NY – September 5, 2019 – Ocuphire Pharma, Inc., a clinical-stage pharmaceutical company and partner of iuvo BioScience’s ophthalmic-focused Oculos Division, announced that it has successfully enrolled 39 glaucoma patients in ORION-1 at 5 U.S. sites from late May to August 2019.  Ocuphire has been collaborating closely with Oculos Development Services to achieve these clinical […]